Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K140834
    Manufacturer
    Date Cleared
    2014-04-25

    (23 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    TERASON USMART3400 ULTRASOUND SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Teratech Corporation Terason™ uSmart3400 is a general purpose Ultrasound System intended for use by a qualified physician for evaluation by ultrasound imaging or fluid flow analysis of the human body. Specific clinical applications and exam types include: Fetal, Abdominal, Pediatric, Small Organ (thyroid, breast, testes), Neonatal Cephalic, Adult Cephalic, Musculoskeletal (conventional and superficial), Cardiac (adult and pediatric), and Peripheral Vascular.

    Device Description

    The Terason™ uSmart3400 ultrasound system is a portable, full-featured ultrasound system used to acquire and display high-resolution, real-time ultrasound data using multiple image modes. This system contains a proprietary ultrasound engine (identical to the predicate device Terason t3200 ultrasound system) for controlling the acoustic output of the transducer and processing the return echoes in real time. These data are then transferred to the host singleboard computer (previously laptop computer) over a FireWire (aka IEEE 1394) connection for further processing and generation and display of the ultrasound image. Three transducers (15L4, 5C2A, 4V2A) connect to the system using the identical connector to the predicate device, Terason t3200.

    The Terason™ uSmart3400 ultrasound EBook weighs 14.6 pounds and has a 15.3" backlit screen. The system dimensions (3.5"(H) x 15.3"(W) x 15.6"(D)) are chosen to allow the system to be hand carried. A Lithium-Polymer battery (integrated into the EBook) provides 2 hours of continuous ultrasound scanning. The system includes a medical-grade power supply (for charging). The ultrasound transducer connector is identical to that used in the Terason™ predicate device, the t3200. Optional accessories include a cart and printer.

    AI/ML Overview

    The provided information describes a 510(k) summary for the Terason™ uSmart3400 Ultrasound System, which is a premarket notification to the FDA to demonstrate that the device is substantially equivalent to legally marketed predicate devices. This type of submission focuses on comparing the new device to existing cleared devices rather than providing detailed clinical study results with specific performance metrics against defined acceptance criteria in the manner one might find for a novel AI-powered diagnostic device.

    Therefore, the following information is extracted and presented based on the context of this 510(k) summary. Acceptance criteria and performance are primarily discussed in terms of substantial equivalence to predicate devices through technical comparisons and compliance with relevant standards.

    1. Table of Acceptance Criteria and Reported Device Performance

    For this 510(k) submission, the "acceptance criteria" are compliance with established medical device standards and demonstrating substantial equivalence to predicate devices, particularly regarding safety and effectiveness. The "reported device performance" is essentially the comparison of the uSmart3400 and its transducers against the predicate devices across various technical and functional aspects.

    Acceptance Criteria CategorySpecific Criteria (Implicit for Substantial Equivalence)Reported Device Performance / Comparison to PredicateResult
    Intended UseIdentical or equivalent intended use.System: "general purpose Ultrasound System intended for use by a qualified physician for evaluation by ultrasound imaging or fluid flow analysis of the human body." - Matches predicate device's general intended use, though specific applications list varies slightly between predicates (K110020, K112953).
    Transducers (15L4, 5C2A, 4V2A): "identical claims of imaging similar regions in the human body" compared to their previously cleared versions.Met
    Indications for UseSubstantially equivalent clinical applications.System: Fetal, Abdominal, Pediatric, Small Organ (thyroid, breast, testes), Neonatal Cephalic, Adult Cephalic, Musculoskeletal (conventional and superficial), Cardiac (adult and pediatric), and Peripheral Vascular. This list is a subset of a predicate (K110020) and overlaps significantly with another (K112953).
    Transducers: Each transducer (15L4, 5C2A, 4V2A) maintains the identical indications for use as its previously cleared version.Met
    Technology CharacteristicsEquivalent core technology, or changes do not raise new safety/effectiveness concerns.Engine: Identical proprietary ultrasound engine to predicate Terason t3200, including beamformer chip. Connectors are identical.
    Software: Modified for improved user workflow and ease of use, considered "commensurate with a diagnostic medical ultrasound application."
    Main Chassis: Replaces laptop computer in predicates, housing engine. Different form factor, weight, and display size but ultrasound engine, communication protocol, and hours of continuous operation are same.
    Transducers: 15L4, 5C2A, 4V2A are stated to use the "same acoustic array" and "same patient contact materials" as their predicate versions.Met
    Acoustic OutputCompliance with acoustic output standards (NEMA UD 2 & 3, IEC 60601-2-37). Safety limits are not exceeded or are equivalent.Global Maximum Outputs for the 15L4 transducer are given and compared to predicate 15L4. Values are similar (e.g., ISPTA.3: 618.4 mW/cm² vs 562.1 mW/cm²; MI: 1.75 vs 1.70). Acoustic output testing per IEC60601-2-37 was performed for all transducers.Met
    Modes of OperationEquivalent imaging modes.Terason uSmart3400 supports B-Mode, Tissue Harmonic, Anatomical M-Mode, Color M-Mode, Color Power Doppler, Velocity Color Doppler, Duplex/Triplex - Doppler imaging, Pulsed Wave (PW) Doppler, and TeraVision II Postprocessing. This set of modes is either identical or a subset of the predicate devices.Met
    Product SafetyCompliance with relevant electrical and medical device safety standards.Compliance achieved for: IEC60601-1, IEC60601-1-2, IEC60601-1-6, IEC60601-2-37.Met
    Electromagnetic Compatibility (EMC)Compliance with EMC standards.CISPR11 Class B. Tested per IEC60601-1-2.Met
    BiocompatibilityPatient contact materials are biocompatible and equivalent.All transducers use same patient contact materials as their predicate versions (e.g., Silicone SIM R1001 for 15L4, Silicone ABS for 5C2A, Silicone Valox for 4V2A). Biocompatibility tests (ISO 10993 Part 5 and Part 10) were performed.Met
    Quality SystemsManufactured under Good Manufacturing Practices (GMPs) and ISO-13485 quality systems.Stated compliance with FDA GMPs and ISO-13485.Met

    Study Details:

    Detailed analysis of "studies" within the context of this 510(k) summary:

    It's crucial to understand that a 510(k) submission primarily relies on demonstrating substantial equivalence to a predicate device, rather than conducting new, large-scale clinical trials that would define novel acceptance criteria and extensive performance metrics. The "studies" referenced are conformity assessments against recognized standards and technical comparisons.

    2. Sample Size Used for the Test Set and Data Provenance:

    • Test Set Sample Size: Not applicable in the context of clinical performance evaluation studies for this 510(k). The "testing" involves technical compliance to standards and comparison of specifications.
    • Data Provenance: The data primarily comes from bench testing, engineering analysis, and comparisons to specifications of previously cleared devices.
      • Acoustic output testing was performed per IEC60601-2-37.
      • Biocompatibility testing per ISO 10993 Parts 5 and 10.
      • Electrical and EMC testing per IEC 60601 series and CISPR11.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:

    • Not applicable. The ground truth here is the adherence to recognized medical device standards and the established safety and performance characteristics of the predicate devices. Experts involved would be engineers, regulatory specialists, and standard body members who define these compliance requirements, not clinical experts establishing ground truth for diagnostic accuracy.

    4. Adjudication Method for the Test Set:

    • Not applicable. There is no clinical test set requiring adjudication of diagnostic outcomes.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

    • No. This type of study is typically conducted for AI-powered diagnostic devices to assess the comparative performance of human readers with and without AI assistance. This 510(k) is for a conventional ultrasound system and does not involve AI.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study:

    • No. This is not an AI algorithm.

    7. Type of Ground Truth Used:

    • Engineering and Regulatory Standards (e.g., IEC 60601 series, NEMA UD series, ISO 10993, CISPR11): These standards define the "ground truth" for safety, electrical performance, acoustic output, and biocompatibility.
    • Predicate Device Specifications and Performance: The performance and safety of the previously cleared predicate devices serve as the benchmark for "ground truth" for substantial equivalence.

    8. Sample Size for the Training Set:

    • Not applicable. This is not an AI device that requires a training set.

    9. How the Ground Truth for the Training Set Was Established:

    • Not applicable.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1